Vitalhub (TSE:VHI) Given a C$13.50 Price Target by Raymond James Analysts

Vitalhub (TSE:VHI) received a C$13.50 price objective from equities researchers at Raymond James in a report released on Thursday,BayStreet.CA reports. The brokerage presently has an “outperform” rating on the stock. Raymond James’ price target indicates a potential upside of 31.84% from the stock’s previous close.

Several other brokerages have also issued reports on VHI. Scotiabank set a C$14.00 price target on Vitalhub and gave the stock an “outperform” rating in a research note on Thursday, January 30th. Canaccord Genuity Group boosted their target price on Vitalhub from C$12.00 to C$12.50 and gave the stock a “buy” rating in a research report on Thursday, January 16th. Four analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus price target of C$11.92.

Vitalhub Stock Performance

Vitalhub stock opened at C$10.24 on Thursday. Vitalhub has a fifty-two week low of C$5.80 and a fifty-two week high of C$12.09. The firm’s fifty day moving average price is C$10.48 and its 200-day moving average price is C$10.32. The stock has a market cap of C$553.91 million, a P/E ratio of 166.55, a price-to-earnings-growth ratio of 1.18 and a beta of 1.26.

About Vitalhub

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.